Dual disorders, also known as co-occurring disorders, refer to the simultaneous presence of both a substance use disorder and a mental health disorder in an individual. These conditions often interact and exacerbate each other, leading to more severe symptoms and complicating the treatment process. Common mental health disorders that frequently coexist with substance use disorders include depression, anxiety disorders, bipolar disorder, and schizophrenia. Dual disorders can manifest in various combinations and degrees of severity, making accurate diagnosis and effective treatment challenging.
Treatment for dual disorders typically involves an integrated approach that addresses both the substance use disorder and the co-occurring mental health disorder concurrently. This approach aims to provide comprehensive care tailored to the individual's unique needs and challenges. Integrated treatment may include a combination of pharmacotherapy, psychotherapy, behavioral interventions, and support services. By addressing both substance use and mental health issues simultaneously, dual disorders treatment seeks to promote recovery, improve overall functioning, and enhance the individual's quality of life. Additionally, ongoing monitoring and support are essential to address any relapse risks and ensure sustained progress in managing dual disorders.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States